Pharma
Revolution Medicines' pancreatic cancer pill Rasonque wins EU committee backing
The agency's committee recommended the daily pill for adults whose pancreatic cancer has spread and who have had earlier treatment. The European Commission makes the final decision and, the agency said, will fast-track it.